title: Brain tissue pO2-monitoring in comatose patients: implications for therapy.
abstract: Monitoring of brain tissue partial pressure of O2 (ti-pO2) is a promising new technique that allows early detection of impending cerebral ischemia in brain-injured patients. The purpose of this study was to investigate the effects of standard therapeutic interventions used in the treatment of intracranial hypertension in comatose patients on cerebral oxygenation. In the neurosurgical intensive care unit ti-pO2, arterial blood pressure, intracranial pressure (ICP), cerebral perfusion pressure (CPP) and jugular bulb oxygen saturation (SjvO2) were prospectively studied (0.1 Hz acquisition rate) in 23 comatose patients (21 with severe traumatic brain injury, 2 with intracerebral hematoma) during various treatment modalities: elevation of CPP with dopamine (n = 35), lowering of the head (n = 22), induced arterial hypocapnia (n = 13), mannitol infusion (n = 16), and decompressive craniotomy (n = 1). Ischemic episodes ('IE' = ti-pO2 < 10 mmHg for > 15 min) within the first week after the insult were always associated with unfavorable neurological outcome. Elevation of CPP from 32 +/- 2 to 67 +/- 4 mmHg significantly improved ti-pO2 by 62% (13 +/- 2 to 21 +/- 1 mmHg) and reduced ICP indicating intact cerebral autoregulation. Further raising CPP from 68 +/- 2 to 84 +/- 2 mmHg did not alter ti-pO2. Mannitol-induced ICP reduction from 23 +/- 1 to 16 +/- 2 mmHg did not affect ti-pO2, nor did lowering of the head from 30 degrees to 0 degree. Hyperventilation from an endtidal pCO2 of 29 +/- 3 to 21 +/- 3 mmHg normalized ICP and CPP, but significantly reduced ti-pO2 from 31 +/- 2 to 14 +/- 3 mmHg. Decompressive craniotomy in a 15-year old patient with refractory intracranial hypertension instantly restored ti-pO2. Based on the present data, our understanding of many interventions previously believed to improve brain oxygenation might have to be re-evaluated. A CPP > 60 mmHg emerges as the most important factor determining sufficient brain tissue pO2. Any intervention used to further elevate CPP does not improve ti-pO2, to the contrary, hyperventilation even bears the risk of inducing brain ischemia.
authors.affiliation: Virchow-Medical Center, Department of Neurosurgery, Humboldt-University of Berlin, Germany.
authors.forename: K L
authors.initials: KL
authors.lastname: Kiening
authors.forename: R
authors.initials: R
authors.lastname: Härtl
authors.forename: A W
authors.initials: AW
authors.lastname: Unterberg
authors.forename: G H
authors.initials: GH
authors.lastname: Schneider
authors.forename: T
authors.initials: T
authors.lastname: Bardt
authors.forename: W R
authors.initials: WR
authors.lastname: Lanksch
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001921:Brain / Q000098:blood supply / Q000378:metabolism / Q000601:surgery; D001923:Brain Chemistry; D001930:Brain Injuries / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D002560:Cerebrovascular Circulation; D003128:Coma / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D003627:Data Interpretation, Statistical; D019299:Decompression, Surgical; D005260:Female; D018475:Head-Down Tilt; D006801:Humans; D006985:Hyperventilation / Q000150:complications; D016857:Hypocapnia / Q000150:complications; D002534:Hypoxia, Brain / Q000209:etiology; D007427:Intracranial Pressure / Q000187:drug effects; D008297:Male; D008353:Mannitol / Q000008:administration & dosage; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010100:Oxygen / Q000032:analysis*; D010313:Partial Pressure; D012121:Respiration, Artificial / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D008353:Mannitol; D010100:Oxygen